Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

PUBLICATION DATE

7 results
Display

Infiltrative hepatocellular carcinoma with multiple lung metastasis completely cured using nivolumab: a case report

Han JE, Cho HJ, Kim SS, Cheong JY

The current Food and Drug Administration-approved systemic treatments for advanced hepatocellular carcinoma (HCC) include multikinase inhibitors (tyrosine kinase inhibitor [TKI]) and immune checkpoint inhibitors (ICIs). Among ICIs, nivolumab is used...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Sorafenib-induced Pancreatic Pseudocyst in a Patient with Advanced Hepatocellular Carcinoma: a Rare Adverse Event

Kim DH, Kim M, Yim HJ, Suh SJ, Jung YK

A 54-year old man diagnosed with advanced hepatocellular carcinoma began treatment with sorafenib. After 3 weeks of treatment, he complained of abdominal pain and nausea. Abdominal sonography showed multiple hepatic...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Genomic Landscape and Its Clinical Implications in Hepatocellular Carcinoma

Yim SY, Lee JS

The pathogenesis of hepatocellular carcinoma (HCC) is a complex process. During the last decade, advances in genomic technologies enabled delineation of the genomic landscape of HCC, resulting in the identification...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Liver Transplantation for Advanced Hepatocellular Carcinoma

Lee KW, Suh KS

Hepatocellular carcinoma (HCC) has become an important indication for liver transplantation in Korea. Even though the Milan criteria have been accepted as the gold standard in deceased donor liver transplantation,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Expanded Criteria for Living Donor Liver Transplantation in Patients with Advanced Hepatocellular Carcinoma

Lee KK, Youn YC, Hwang JK, Park JH, Kim JI, Yoo YK, Moon IS, Kim DG

  • KMID: 2083319
  • Korean J Hepatobiliary Pancreat Surg.
  • 2009 Sep;13(3):171-178.
PURPOSE: The purpose of this study was to evaluate the possibility of expanding the indication for living donor liver transplantation (LDLT) for treatment of hepatocellular carcinoma (HCC), beyond the Milan...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
High dose regional chemotherapy in advanced hepatocellular carcinoma with 4-lumen-2-balloon catheter

Hwang YJ, Kim JW, Kim YI

  • KMID: 2244359
  • Korean J Hepatobiliary Pancreat Surg.
  • 2000 Oct;4(2):101-106.
BACKGROUND: Surgical resection is the mainstay for treatment of HCC. However, resction is often not feasible in patients with advanced HCC. Patients excluded from surgery, may be treated with systemic...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Phase II Study of AP (Doxorubicin, Cisplatin) Chemotherapy in Patients with Advanced Hepatocellular Carcinoma

Lee JA, Kang YK, Kim CM, Lee JO, Kang TW

  • KMID: 1531923
  • J Korean Cancer Assoc.
  • 1997 Feb;29(1):103-110.
PURPOSE: Hepatocellular carcinoma (HCC) is the most common form of primary hepatic carcinoma and is considered to be a highly malignant tumor with poor prognosis. We evaluated the efficacy and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2023 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr